She suffered from Sjogren syndrome and inflammatory arthritis and was currently treated with prednisone and methotrexate. She was previously treated with hydroxychloroquine (Plaquenil) 200mg bid (6.5mg/kg) for 10 years, which was stopped one year prior to presentation. Prednisone vs plaquenil What is chloroquine made up of Chloroquine phosphate for rheumatoid arthritis Abstract. Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. Ophthalmology. 2011 Oct;118102100; author reply 2101. BACKGROUND The American Academy of Ophthalmology recommendations for screening of chloroquine CQ and hydroxychloroquine HCQ retinopathy were published in 2002, but improved screening tools and new knowledge about the prevalence of toxicity have appeared in the ensuing years. My Take on New Ocular Screening Guidelines for Plaquenil By Sergio Schwartzman, MD 12 October 2016 A recent article published by the American Academy of Ophthalmology AAO presented new recommendations for screening of patients being managed with hydroxychloroquine HCQ. Review of systems: Blurred vision, halos, dry eye, dry mouth, gastroesophageal reflux, joint pain Pupils: Reactive to light in each eye from 5 mm in the dark to 2 mm in the light. Extraocular movements: Full, both eyes (OU) Confrontation visual fields: Full OU Intra-ocular pressure The optic nerves appeared healthy with a 0.3 cup-to-disc ratio. Past Ocular History: None Medical History: Sjogren syndrome and inflammatory arthritis, supraventricular tachycardia, anxiety, depression, peptic ulcer disease Medications: prednisone, methotrexate, amitriptyline, ranitidine, estradiol, tizanidine, diltiazem, Restasis Allergies: codeine, droperidol Family History: heart disease, arthritis, cancer Social History: occasional alcohol but no tobacco or intravenous drug use. Plaquenil retinopathy screening guidelines 2011 Hydroxychloroquine Plaquenil Toxicity and., Revised recommendations on screening for chloroquine and. 60 increase in malaria deaths after chloroquine failurePlaquenil sulfaPlaquenil psoriasis arthritisHydroxychloroquine alcohol Hydroxychloroquine Retinopathy Still Alive and Well. May 16, 2011 • By Michael F. Marmor, MD. Tweet;. Revised Retinopathy Screening Guidelines State Risks Linked to Hydroxychloroquine, Chloroquine. May 2011. Duration of Use. After five to seven years of HCQ use, the risk of retinal toxicity is above 1%, and the AAO recommends annual. Hydroxychloroquine Retinopathy Still Alive and Well - Page.. My Take on New Ocular Screening Guidelines for Plaquenil RheumNow.. AMERICAN COLLEGE OF RHEUMATOLOGY. Background. The American Academy of Ophthalmology recommendations for screening of chloroquine CQ and hydroxychloroquine HCQ retinopathy were published in 2002, but improved screening tools and new knowledge about the prevalence of toxicity have appeared in the ensuing years. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;1182. Comparison of Screening Procedures in Hydroxychloroquine Toxicity. AMA Manual of Style Art and Images in Psychiatry Breast Cancer Screening Guidelines Colorectal Screening Guidelines Declaration of Helsinki Depression. Plaquenil Retinopathy Screening Requirements Are You Up to Date on the New Standards. In 2011 the American Academy of Ophthalmology published new clinical guidelines for appropriate annual screenings for those patients taking Plaquenil. These guidelines are much different from the previous 2002 recommendations, and many practicing doctors.